The key distinction between primary and secondary pharmaceutical packaging is drug contact. Primary packaging components directly contact, or may directly contact, the dosage form. Secondary packaging surrounds that primary packaging without directly contacting the drug. A vial and stopper, for example, may form part of the primary packaging system, while the folding carton holding the vial is typically secondary packaging.
The two layers have different responsibilities, but they should not be developed independently. The primary container affects the insert, carton dimensions, labeling area, artwork, and ultimately the complete packaging system.
Packaging terminology and regulatory requirements vary by market and product type. The U.S. and EU examples below explain the distinction but do not replace product-specific regulatory review.
Primary vs Secondary Pharmaceutical Packaging at a Glance
| Factor | Primary Packaging | Secondary Packaging |
|---|---|---|
| Drug contact | Direct or potential direct contact with the dosage form | Normally no direct contact with the dosage form |
| Main purpose | Contain and directly protect the drug product | Protect, organize, identify, and support the packaged product |
| Common examples | Vials, bottles, ampoules, drug-contact blister components, stoppers and closures | Folding cartons, outer cartons, and some protective overwraps |
| Material considerations | Closely tied to compatibility and protection of the drug | Different risk profile, but still important to the complete packaging system |
| Artwork space | Often limited by container size and shape | Usually provides more space for product information |
| Structural dependency | Designed around the dosage form | Designed around the primary package, insert, and required clearance |
What Is Primary Packaging in Pharmaceuticals?
FDA‘s current final guidance defines a primary packaging component as one that is or may be in direct contact with the dosage form. It also defines the container closure system as the combination of packaging components that together contain and protect the dosage form.
Common Primary Packaging Examples
Depending on the product, primary components can include vials, ampoules, bottles, drug-contact blister components, stoppers, caps, seals, and other components that can contact the dosage form. For example, describing a glass vial as the primary package while ignoring the stopper would give an incomplete picture. The closure may also be part of the drug-contact system and therefore has its own functional importance.
What Primary Packaging Has to Do
The main responsibility of primary packaging is the drug product itself.
It has to contain the dosage form and provide the protection required by the approved packaging system. Depending on the product, that can involve protection from factors such as moisture, light, gases, leakage, or microbial contamination. Compatibility also matters because the drug product and drug-contact components should not interact in a way that causes unacceptable changes in product quality.
Those are pharmaceutical-development questions rather than simply graphic-design decisions. A secondary packaging supplier should not be assumed to perform drug-container compatibility validation unless that responsibility has been explicitly established.
What Is Secondary Packaging in Pharmaceuticals?
Secondary packaging does not normally contact the dosage form directly. Instead, it surrounds and supports the packaged drug product. A simple example follows: drug product → vial and stopper → folding carton.
Within this setup, the vial and associated closure components form the primary packaging, while the carton is a secondary component. FDA’s final guidance specifically identifies cartons and overwraps as examples of secondary packaging components.
Common Secondary Packaging Examples
The most prevalent form is the folding carton. Secondary packaging also includes protective overwraps.
Inserts, trays, and dividers are often placed inside folding cartons to hold primary containers such as bottles or vials in position. When they do not come into direct contact with the drug product, they can serve as supporting components within the secondary packaging system by helping separate, organize, and protect the primary containers.
What Secondary Packaging Has to Do
Secondary packaging often has several jobs at once. It can protect the primary package from handling, organize one or multiple containers, provide larger surfaces for labeling information, and help distinguish the product or SKU during storage and use. It may also provide functional protection beyond the primary package.
Secondary Packaging Can Still Protect the Drug Product
It is easy to think of secondary packaging as only a printed box. In pharma, that can be misleading.
FDA guidance notes that secondary packaging may provide additional protection from light, moisture or solvent transmission, reactive gases, rough handling, and, in some packaging systems, microbial intrusion. When the product relies on that secondary layer for protection, its performance needs to be supported by appropriate evaluation or data.
That does not mean every folding carton provides the same level of protection. A standard paperboard carton, for example, should not automatically be described as moisture-resistant or as providing validated light protection. Its actual protective role depends on the material, structure, the rest of the packaging system, and how the package has been evaluated.
Primary Packaging Determines the Secondary Package
From a production perspective, one of the most important relationships is dimensional. The secondary carton should be developed around the complete primary package.
CNN Package encountered this in a peptide-vial project using an EVA insert. The initial insert design was based too closely on the bare vial dimensions and did not allow enough space for the foam wall thickness and assembly clearance. Once those requirements were accounted for, the insert became larger and the outer carton also had to increase in size. That affected both tooling and the project timeline.
The practical sequence should therefore be:
Primary container → closure and maximum dimensions → insert → assembly clearance → carton dimensions → dieline → artwork
Labels and Cartons Need to Work as One Information System
The primary container and secondary carton may be physically different components, but the information across them needs to remain coordinated.
Product identity, strength, SKU, lot and expiry areas, and machine-readable data may appear across both the container label and outer carton, depending on the product and market. These elements should be developed from the correct approved artwork version rather than managed as unrelated files. At CNN Package, repeat orders are checked against master artwork and previous version records, and changed files are reviewed before production. For barcode and QR-code projects, the source data and scanability are also checked where relevant.
For packaging buyers, the key point is simple: any change to important product information should be reviewed across every affected packaging component before production.
Primary vs Secondary Packaging in the U.S. and EU: Terminology Matters
The underlying concept is similar across major markets, but the vocabulary is not identical.
FDA’s current final 1999 guidance uses primary packaging component and secondary packaging component. It defines primary components around direct or possible direct dosage-form contact. FDA issued a new Container Closure Systems guidance in August 2026, but as of September 2026 it remains a draft guidance, not for implementation. The current article therefore does not treat that draft as replacing FDA’s final guidance.
In the EU, Directive 2001/83/EC uses the terms immediate packaging and outer packaging. Immediate packaging is the container or other packaging directly in contact with the medicinal product, while outer packaging is the packaging into which that immediate packaging is placed.
So the concepts overlap, but packaging teams should use the terminology applicable to their target market and regulatory documents.
What About Tertiary Packaging?
Tertiary packaging is the outer packaging used to group multiple packaged products together for storage, handling, and transportation.
A common pharmaceutical example is a corrugated shipping case containing multiple folding cartons. Those shipping cases may then be stacked and secured on a pallet for warehouse handling and distribution.
Unlike primary and secondary packaging, tertiary packaging is mainly designed around logistics rather than the presentation of an individual drug product.
What Should Be Finalized Before Designing Secondary Packaging?
Before a secondary carton or insert moves into final artwork, the packaging supplier should have reliable information about the primary container. That includes the actual container type, maximum assembled dimensions, stopper or closure dimensions, number of units per carton, insert requirements, and any required assembly clearance. The supplier should also receive the approved artwork content, target market, variable-data areas, barcode or data-code files where applicable, and relevant shipping or handling requirements.
For healthcare and pharmaceutical packaging, CNN Package can support secondary components such as labels, folding cartons, inserts, and related printed packaging based on the confirmed primary-container configuration and approved artwork.
